We are live on
!
Find out more
PDLI
PDL BioPharma, Inc.
PDLI
PDLI
Delisted
PDLI was delisted on the 30th of December, 2020.
148 hedge funds and large institutions have $332M invested in PDL BioPharma, Inc. in 2019 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 38 increasing their positions, 64 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
837% more call options, than puts
Call options by funds: $356K | Put options by funds: $38K
6% less funds holding
Funds holding: 157 → 148 (-9)
24% less capital invested
Capital invested by funds: $437M → $332M (-$105M)
35% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 20
41% less repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 64
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
148
Holders Change
-9
Holders Change %
-5.73%
% of All Funds
3.21%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
13
Increased
38
Reduced
64
Closed
20
Calls
$356K
Puts
$38K
Net Calls
+$318K
Net Calls Change
-$20K
Top Buyers
| 1 |
N
Nuveen
Charlotte,
North Carolina
|
+$1.79M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$1.62M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$1.48M |
| 4 |
State Street
Boston,
Massachusetts
|
+$1.46M |
| 5 |
CEP
Chicago Equity Partners
Chicago,
Illinois
|
+$1.43M |
Top Sellers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$4.23M |
| 2 |
BlackRock
New York
|
-$4.2M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$3.23M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$2.93M |
| 5 |
Morgan Stanley
New York
|
-$2.77M |
